|
1
|
Caudill JS and Arndt CA: Diagnosis and
management of bone malignancy in adolescence. Adolesc Med State Art
Rev. 18:62–78. 2007.PubMed/NCBI
|
|
2
|
Sissons HA: The WHO classification of bone
tumors. Recent Results Cancer Res. 54:104–108. 1976.PubMed/NCBI
|
|
3
|
Mason NJ: Comparative immunology and
immunotherapy of canine osteosarcoma. Adv Exp Med Biol.
1258:199–221. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
von Eisenhart-Rothe R, Toepfer A, Salzmann
M, Schauwecker J, Gollwitzer H and Rechl H: Primary malignant bone
tumors. Orthopade. 40:1121–1142. 2011.(In German). View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jaffe N, Carrasco H, Raymond K, Ayala A
and Eftekhari F: Can cure in patients with osteosarcoma be achieved
exclusively with chemotherapy and abrogation of surgery? Cancer.
95:2202–2210. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Berto A, Yu J, Morchoisne-Bolhy S,
Bertipaglia C, Vallee R, Dumont J, Ochsenbein F, Guerois R and Doye
V: Disentangling the molecular determinants for Cenp-F localization
to nuclear pores and kinetochores. EMBO Rep. 19:e447422018.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shahid M, Lee MY, Piplani H, Andres AM,
Zhou B, Yeon A, Kim M, Kim HL and Kim J: Centromere protein F
(CENPF), a microtubule binding protein, modulates cancer metabolism
by regulating pyruvate kinase M2 phosphorylation signaling. Cell
Cycle. 17:2802–2818. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Erlanson M, Casiano CA, Tan EM, Lindh J,
Roos G and Landberg G: Immunohistochemical analysis of the
proliferation associated nuclear antigen CENP-F in non-Hodgkin's
lymphoma. Mod Pathol. 12:69–74. 1999.PubMed/NCBI
|
|
9
|
Cheng Y, Wang K, Geng L, Sun J, Xu W, Liu
D, Gong S and Zhu Y: Identification of candidate diagnostic and
prognostic biomarkers for pancreatic carcinoma. EBioMedicine.
40:382–393. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sun J, Huang J, Lan J, Zhou K, Gao Y, Song
Z, Deng Y, Liu L, Dong Y and Liu X: Overexpression of CENPF
correlates with poor prognosis and tumor bone metastasis in breast
cancer. Cancer Cell Int. 19:2642019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sun B, Lin G, Ji D, Li S, Chi G and Jin X:
Dysfunction of sister chromatids separation promotes progression of
hepatocellular carcinoma according to analysis of gene expression
profiling. Front Physiol. 9:10192018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Alghamdi M, Alkhamis WH, Bashiri FA,
Jamjoom D, Al-Nafisah G, Tahir A and Abdouelhoda M: Expanding the
phenotype and the genotype of Stromme syndrome: A novel variant of
the CENPF gene and literature review. Eur J Med Genet.
63:1038442020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen EB, Qin X, Peng K, Li Q, Tang C, Wei
YC, Yu S, Gan L and Liu TS: HnRNPR-CCNB1/CENPF axis contributes to
gastric cancer proliferation and metastasis. Aging (Albany NY).
11:7473–7491. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li R, Wang X, Zhao X, Zhang X, Chen H, Ma
Y and Liu Y: Centromere protein F and forkhead box M1 correlation
with prognosis of non-small cell lung cancer. Oncol Lett.
19:1368–1374. 2020.PubMed/NCBI
|
|
17
|
Liu ZK, Zhang RY, Yong YL, Zhang ZY, Li C,
Chen ZN and Bian H: Identification of crucial genes based on
expression profiles of hepatocellular carcinomas by bioinformatics
analysis. PeerJ. 7:e74362019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mahmoud AD, Ballantyne MD, Miscianinov V,
Pinel K, Hung J, Scanlon JP, Iyinikkel J, Kaczynski J, Tavares AS,
Bradshaw AC, et al: The human-specific and smooth muscle
cell-enriched lncRNA SMILR promotes proliferation by regulating
mitotic CENPF mRNA and drives cell-cycle progression which can be
targeted to limit vascular remodeling. Circ Res. 125:535–551. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lokody I: Signalling: FOXM1 and CENPF:
Co-pilots driving prostate cancer. Nat Rev Cancer. 14:450–451.
2014. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lin SC, Kao CY, Lee HJ, Creighton CJ,
Ittmann MM, Tsai SJ, Tsai SY and Tsai MJ: Dysregulation of
miRNAs-COUP-TFII-FOXM1-CENPF axis contributes to the metastasis of
prostate cancer. Nat Commun. 7:114182016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Aytes A, Mitrofanova A, Lefebvre C,
Alvarez MJ, Castillo-Martin M, Zheng T, Eastham JA, Gopalan A,
Pienta KJ, Shen MM, et al: Cross-species regulatory network
analysis identifies a synergistic interaction between FOXM1 and
CENPF that drives prostate cancer malignancy. Cancer Cell.
25:638–651. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li Z, Sang M, Tian Z, Liu Z, Lv J, Zhang F
and Shan B: Identification of key biomarkers and potential
molecular mechanisms in lung cancer by bioinformatics analysis.
Oncol Lett. 18:4429–4440. 2019.PubMed/NCBI
|
|
23
|
Zhang JY, Zhu W, Imai H, Kiyosawa K, Chan
EK and Tan EM: De-novo humoral immune responses to
cancer-associated autoantigens during transition from chronic liver
disease to hepatocellular carcinoma. Clin Exp Immunol. 125:3–9.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hong Y, Long J, Li H, Chen S, Liu Q, Zhang
B, He X, Wang Y, Li H, Li Y, et al: An analysis of immunoreactive
signatures in early stage hepatocellular carcinoma. EBioMedicine.
2:438–446. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li S, Li X, Xu A, Zhang B, He X, Chen H
and Huang J: Screening and clinical evaluation of dominant peptides
of centromere protein F antigen for early diagnosis of
hepatocellular carcinoma. Mol Med Rep. 17:4720–4728.
2018.PubMed/NCBI
|
|
26
|
Wan Z, Zhang X, Luo Y and Zhao B:
Identification of hepatocellular carcinoma-related potential genes
and pathways through bioinformatic-based analyses. Genet Test Mol
Biomarkers. 23:766–777. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang X, Miao BS, Wei CY, Dong RZ, Gao PT,
Zhang XY, Lu JC, Gao C, Wang XY, Sun HC, et al: Lymphoid-specific
helicase promotes the growth and invasion of hepatocellular
carcinoma by transcriptional regulation of centromere protein F
expression. Cancer Sci. 110:2133–2144. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kim HE, Kim DG, Lee KJ, Son JG, Song MY,
Park YM, Kim JJ, Cho SW, Chi SG, Cheong HS, et al: Frequent
amplification of CENPF, GMNN and CDK13 genes in hepatocellular
carcinomas. PLoS One. 7:e432232012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Göbel C, Özden C, Schroeder C, Hube-Magg
C, Kluth M, Möller-Koop C, Neubauer E, Hinsch A, Jacobsen F, Simon
R, et al: Upregulation of centromere protein F is linked to
aggressive prostate. cancers. Cancer Manag Res. 10:5491–5504. 2018.
View Article : Google Scholar
|
|
30
|
O'Brien SL, Fagan A, Fox EJ, Millikan RC,
Culhane AC, Brennan DJ, McCann AH, Hegarty S, Moyna S, Duffy MJ, et
al: CENP-F expression is associated with poor prognosis and
chromosomal instability in patients with primary breast cancer. Int
J Cancer. 120:1434–1443. 2007. View Article : Google Scholar
|
|
31
|
Zhuo YJ, Xi M, Wan YP, Hua W, Liu YL, Wan
S, Zhou YL, Luo HW, Wu SL, Zhong WD and Wu CL: Enhanced expression
of centromere protein F predicts clinical progression and prognosis
in patients with prostate cancer. Int J Mol Med. 35:966–972. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cao JY, Liu L, Chen SP, Zhang X, Mi YJ,
Liu ZG, Li MZ, Zhang H, Qian CN, Shao JY, et al: Prognostic
significance and therapeutic implications of centromere protein F
expression in human nasopharyngeal carcinoma. Mol Cancer.
9:2372010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Dai Y, Liu L, Zeng T, Zhu YH, Li J, Chen
L, Li Y, Yuan YF, Ma S and Guan XY: Characterization of the
oncogenic function of centromere protein F in hepatocellular
carcinoma. Biochem Biophys Res Commun. 436:711–718. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Koon N, Schneider-Stock R, Sarlomo-Rikala
M, Lasota J, Smolkin M, Petroni G, Zaika A, Boltze C, Meyer F,
Andersson L, et al: Molecular targets for tumour progression in
gastrointestinal stromal tumours. Gut. 53:235–240. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mi YJ, Gao J, Xie JD, Cao JY, Cui SX, Gao
HJ, Yao SP, Liu T, Zhang YY, Guo CH, et al: Prognostic relevance
and therapeutic implications of centromere protein F expression in
patients with esophageal squamous cell carcinoma. Dise Esophagus.
26:636–643. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Laoukili J, Kooistra MR, Brás A, Kauw J,
Kerkhoven RM, Morrison A, Clevers H and Medema RH: FoxM1 is
required for execution of the mitotic programme and chromosome
stability. Nat Cell Biol. 7:126–136. 2005. View Article : Google Scholar : PubMed/NCBI
|
